Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Preventive Treatment in Pregnancy With Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine to Prevent Malaria Infection and Reduce Adverse Pregnancy Outcomes in Papua New Guinea - a Randomised Controlled Trial

NCT05426434 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.

NCT NCT05426434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05426434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Preventive Treatment in Pregnancy With Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine to Prevent Malaria Infection and Reduce Adverse Pregnancy Outcomes in Papua New Guinea - a Randomised Controlled Trial
Lead sponsor
Menzies School of Health Research
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 31, 2022
Completion date
December 31, 2025
Enrollment
1,172 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, malaria in pregnancy, pregnancy related